Abstract: A method and system for generating a variable rate irrigation (VRI) prescription map for a large sprinkler irrigation system is provided. The method includes: determining a minimum length of a VRI management zone along a truss direction of the sprinkler irrigation system; determining a minimum angle of the VRI management zone along a travel direction of the sprinkler irrigation system; dividing the VRI management zone to generate a VRI management zoning map; determining, according to a basic irrigation amount of VRI management and a spatial distribution map of crop water deficit or a spatial distribution map of soil water holding capacity (SWHC), an irrigation quota of each management sub-zone; and generating, according to a distribution map of irrigation quotas of all management sub-zones in combination with a travel speed of the sprinkler irrigation system and a duty cycle of a solenoid valve, the VRI prescription map.

Abstract: A decision-making method for variable rate irrigation management includes the following steps: S1: sampling a soil from a root zone of a crop in an area controlled by an irrigation sprinkler, and measuring compositions of separates of the sampled soil; S2: managing and dividing the area controlled by the irrigation sprinkler according to an AWC of the soil in the root zone of the crop; S3: constructing an optimized soil moisture sensor network; S4: placing ground-fixed canopy temperature sensors; S5: constructing an optimized airborne canopy temperature sensor network centered on the center pivot; and S6: performing a variable rate irrigation by using the optimized soil moisture sensor network, the fixed canopy temperature sensors, the optimized airborne canopy temperature sensor network and an automatic weather station. The method optimizes the placement and quantity of the soil moisture sensor network and the canopy temperature sensor network to improve the measurement accuracy.

Abstract: An optical device includes an LED chip, a light absorber and/or visible-light luminescent material, and a near-infrared luminescent material, wherein a luminous power of light emitted by the near-infrared luminescent material and the light absorber and/or visible-light luminescent material in a band of 650-1000 nm under the excitation of the LED chip is A, and a sum of a luminous power of light emitted by the near-infrared and visible-light luminescent materials in a band of 350-650 nm under the excitation of the LED chip and a luminous power of residual light emitted by the LED chip in the band of 350-650 nm after the LED chip excites the near-infrared and visible-light luminescent materials is B, with B/A*100% being 0.1%-10%. According to the implementation where the optical device employs the LED chip to combine the near-infrared luminescent material and the light absorber and/or visible-light luminescent material simultaneously.

Abstract: A computer readable storage medium is provided. When contents of the computer readable storage medium are executed by a processor, multi-photon imaging may be performed on a histopathological section containing tumor environment information, and pathological partitioning of a tumor microenvironment may be further performed through image processing. A value of each collagen feature parameters, such as a morphological feature parameter, an energy feature parameter and a texture feature parameter, may be extracted from a tumor tissue region, an invasive margin (IM) region and a normal tissue (N) region. An inter-region difference and a variation may be calculated according to feature parameters of regions. A collagen feature scoring model may be established. A collagen feature score may be calculated with the collagen feature parameters input to the model.

Abstract: The invention relates to a phosphor with garnet structure and a light-emitting device comprising the phosphor, wherein the phosphor includes the following components in percentage by weight: 38.47-45.19% of Y element, 9.49-22.09% of Al element, 2.06-24.31% of Ga element, 27.3-32.04% of O element, 0.43-1.46% of Ce element. In the phosphor particles, the shortest distance from the surface of one side of the particle to the surface of the opposite side through the centroid of the particle is defined as R, the longest distance is R1, and 5 ?m?R?40 ?m; any distance from the particle surface to the centroid is r, and 0<r<½R; and the space with the distance from the particle surface to the centroid direction being less than or equal to r is defined as rinner.

Abstract: Disclosed are a display module and a television, the display module including: a back plate including a back plate body and a side wall which are integrally formed, the back plate body and the side wall together defining a mounting space, a free end of the side wall being folded so as to form a connecting flange which extends towards the back plate body, a free end of the connecting flange being folded so as to form a joining flange which extends in parallel with the back plate body; a display screen, an edge of an inside surface of the display screen being fixed to an outer surface of the joining flange; an optical film set mounted in the mounting space.

Abstract: A control method that is applied to a first electronic device, the method including in response to obtaining a trigger signal, determining a target component corresponding to the trigger signal; and sharing the target component with a second electronic device to expand performance of the second electronic device corresponding to the target component, the second electronic device being a device that establishes a target connection with the first electronic device, when the first electronic device is in different power mode, sharing method of the target component is different.

Abstract: The invention provides a Saccharomyces cerevisiae strain for producing a human milk lipid substitute. By integrating a heterologous lysophosphatidic acid acyltransferase into Saccharomyces cerevisiae and knocking out its own natural lysophosphatidic acid acyltransferase, the content of palmitic acid (C16:0) at Sn-2 position of triacylglycerol produced by Saccharomyces cerevisiae is increased, to synthesize a human milk lipid substitute. On this basis, a metabolic pathway related gene is knocked out, to further increase the content of human milk lipid substitute in the product. In the present invention, a human milk lipid substitute is de novo synthesized by Saccharomyces cerevisiae for the first time, in which the total fatty acid is 15% or more, and the relative content of C16:0 at Sn-2 position reaches about 60%.

Abstract: An array substrate has sub-pixel regions arranged in an array, and the sub-pixel regions include white sub-pixel regions and primary color sub-pixel regions. The array substrate includes a first substrate and a plurality of sub-pixels disposed on the first substrate. The sub-pixels include white sub-pixels and primary color sub-pixels. In a column direction, a side of each white sub-pixel is adjacent to at least one primary color sub-pixel. Each sub-pixel has light-shielding patterns. In the column direction, in a plurality of light-shielding patterns of a primary color sub-pixel adjacent to the white sub-pixel, a part of the light-shielding patterns are disposed in a white sub-pixel region where the white sub-pixel is located, and another part of the light-shielding patterns are disposed in a primary color sub-pixel region corresponding to the primary color sub-pixel.

Abstract: A bidirectional DC/DC converter includes a first terminal circuit, a transformer, a second terminal circuit, and a reset circuit, and the transformer includes a first winding and a second winding. The first terminal circuit is coupled to the first winding, and the second terminal circuit and the reset circuit are coupled to the second winding. In a first time period in which the bidirectional DC/DC converter is in a second working state, the second terminal circuit transmits a second alternating current to the first terminal circuit by using the second winding and the first winding; and in a second time period in which the bidirectional DC/DC converter is in the second working state, the reset circuit is in a conducted state, to reset the second winding.

Abstract: The embodiments of the present disclosure provide an array substrate and a method for manufacturing the same, and a display device. The array substrate includes a substrate, wherein the substrate has a display region and a peripheral region surrounding the display region, the display region has a plurality of pixels arranged in an array, and each of the plurality of pixels includes a light transmission region and a light shielding region, and a light shielding block covering at least a part of the light transmission region of at least one pixel close to the peripheral region of the plurality of pixels.

Abstract: An array substrate has sub-pixel regions arranged in an array, and the sub-pixel regions include white sub-pixel regions and primary color sub-pixel regions. The array substrate includes a first substrate and a plurality of sub-pixels disposed on the first substrate. The sub-pixels includes white sub-pixels and primary color sub-pixels. In a column direction, a side of each white sub-pixel is adjacent to at least one primary color sub-pixel. Each sub-pixel has light-shielding patterns. In the column direction, in a plurality of light-shielding patterns of a primary color sub-pixel adjacent to the white sub-pixel, a part of the light-shielding patterns are disposed in a white sub pixel region where the white sub-pixel is located, and another part of the light-shielding patterns are disposed in a primary color sub-pixel region corresponding to the primary color sub-pixel.

Abstract: A pixel electrode, including: a plurality of strip-shaped first electrodes, where the plurality of the first electrodes are arranged along a first direction, each of the first electrodes extends along a second direction, and the second direction intersects with the first direction; a second electrode, where the second electrode is connected to first ends of the plurality of first electrodes, and the first ends of the plurality of first electrodes are connected through the second electrode; and a third electrode, where the third electrode is connected to a second end of at least one of the first electrodes, and a direction of an electric field of an area in which the third electrode is disposed intersects with both the first direction and the second direction.

Abstract: The embodiments of the present disclosure provide an array substrate and a method for manufacturing the same, and a display device. The array substrate includes a substrate, wherein the substrate has a display region and a peripheral region surrounding the display region, the display region has a plurality of pixels arranged in an array, and each of the plurality of pixels includes a light transmission region and a light shielding region, and a light shielding block covering at least a part of the light transmission region of at least one pixel close to the peripheral region of the plurality of pixels.

Abstract: Provided are a chimeric antigen receptor targeting CD20 antigen and a preparation method thereof. The extracellular antigen binding domain of the chimeric antigen receptor includes an antibody heavy chain variable region shown in SEQ ID NO: 7 or 9 or 33 and an antibody light chain variable region shown in SEQ ID NO: 11 or 13 or 35, and is capable of killing tumor cells.

Abstract: The present invention provides a combined chimeric antigen receptor targeting CD19 and CD20 and application thereof. Specifically, the present invention provides a combined chimeric antigen receptor targeting CD19 and CD20, which comprises a scFv targeting CD19 and a scFv targeting CD20, a hinge region, a transmembrane region, and an intracellular signaling domain. The present invention provides a nucleic acid molecule encoding the chimeric antigen receptor and a corresponding expression vector, a CAR-T cell, and applications thereof. The experimental results show that the chimeric antigen receptor provided by the present invention shows extremely high killing ability against tumor cells. The chimeric antigen receptor of the present invention targets CD19 and/or CD20 positive cells and can be used to treat CD19 and/or CD20 positive B-cell lymphoma, leukemia and other diseases.

Abstract: Disclosed is a transient-state THz spectrometer applied to cells and biological macromolecules, including a femtosecond laser amplifier. A femtosecond laser output by the femtosecond laser amplifier is divided into two beams of pump light and probe light after passing through a beam splitter of which a transmission-reflection ratio is 7:3, the pump light is focused to irradiate a gap between electrodes of a nonlinear photoconductive antenna and emit a terahertz wave after successively passing through a half wave plate, a silver-plated reflector and a first lens, the terahertz wave forms a terahertz wave collineation after successively passing through a second lens, a slab waveguide, a third lens and an ITO film, the terahertz wave collineation and the probe light form a probe light collineation of wavefront tilt which is perpendicularly incident on a ZnTe crystal and detected and recorded by using a CCD camera.

Abstract: Provided are a CD22-targeted chimeric antigen receptor, a preparation method therefor and an application thereof. The chimeric antigen receptor comprises a leader sequence, a CD22-targeted scFv, a hinge region, a transmembrane region, and an intracellular signal domain. Provided are a nucleic acid molecule encoding the chimeric antigen receptor and a corresponding expression vector, a CAR-T cell, and an application thereof. The chimeric antigen receptor targets CD22 positive cells and can be used for treating CD22-positive B-cell leukemia, and some CD19-negative and CD22-positive patients in which acute B-cell leukemia has recurred after anti-CD19 CAR-T treatment.

Abstract: The present invention provides a combined chimeric antigen receptor targeting CD19 and CD20 and application thereof. Specifically, the present invention provides a combined chimeric antigen receptor targeting CD19 and CD20, which comprises a scFv targeting CD19 and CD20, a hinge region, a transmembrane region, and an intracellular signaling domain. The present invention provides a nucleic acid molecule encoding the chimeric antigen receptor and a corresponding expression vector, a CAR-T cell, and applications thereof. The experimental results show that the chimeric antigen receptor provided by the present invention shows extremely high killing ability against tumor cells. The chimeric antigen receptor of the present invention targets CD19 and/or CD20 positive cells and can be used to treat CD19 and/or CD20 positive B-cell lymphoma, leukemia and other diseases.

Abstract: Provided is a combined chimeric antigen receptor targeting CD19 and CD20 and application thereof. Specifically, provided is a combined chimeric antigen receptor targeting CD19 and CD20, which comprises a scFv targeting CD19 and CD20, a hinge region, a transmembrane region, and an intracellular signaling domain. Provided is a nucleic acid molecule encoding the chimeric antigen receptor and a corresponding expression vector, a CAR-T cell, and applications thereof. The experimental results show that the chimeric antigen receptor shows extremely high killing ability against tumor cells. The chimeric antigen receptor targets CD19 and/or CD20 positive cells and can be used to treat CD19 and/or CD20 positive B-cell lymphoma, leukemia and other diseases.